Dermatologic aspects of antiphospholipid syndrome

International Journal of Dermatology

Volumn 37, Issue 3, 1998, Pages 173-180

  Gantcheva, Mary ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; REAGINIC ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; DERMATOLOGY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS WASTAGE; GENETIC PREDISPOSITION; LIVEDO RETICULARIS; MALIGNANT NEOPLASTIC DISEASE; REVIEW; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; HUMANS; SKIN DISEASES;

EID: 0031887386     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00416.x     Document Type: Review

References (88)

1. May K, West S, Moulds J, et al. Different manifestation of the antiphospholipid syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 528-533.
2. Bevers E, Galli M, Barbni T, et al. Lupus anticoagulant Ig's are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629.
3. Galli M, Finazzi G, Beveres E, et al. Kaolin-clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and β-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86: 617-623.
4. McNeil H, Simpson R, Chesterman C, et al. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I. Proc Natl Acad Sci USA 1990; 87: 4120.
5. Galli M, Comfurius P, Massen C, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544.
6. Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor and differential diagnosis of autoimmune diseases. Lancet 1990; 336: 177.
7. Galli M, Beveres E. β2-Glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336: 952.
8. Manoussakis M, Tzioufas A, Silis M, et al. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.
9. Shi W, Krilis S, Chong B, et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990; 20: 231.
10. Wasserman A. Uber die Entwisklung und den gegenwartigen Stand der Serodiagnostic gegenuber syphilis. Berl Klin Wchnschr 1907; 44: 1599.
11. Pangborn M. A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 1941; 48: 484-486.
12. Moore J, Mohr C. Biologically false positive serologic tests for syphilis. JAMA 1952; 150: 467-473.
13. Johansson E, Lassus A. The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies. Ann Clin Res 1974; 6: 105-108.
14. Lockshin M. Antiphospholipid antibody syndrome. JAMA 1992; 268: 1451-1453.
15. Hunt J, Adelstein S, Krilis S. New basic aspects of the antiphospholipid syndrome. Clin Exp Rheum 1994; 12: 661-668.
16. Asherson R, Cervera R, Antiphospholipid syndrome. J Invest Dermatol 1993; 100: 21S-27S.
17. Nimpf J, Gries A, Wurm H, et al. Influence of β2-glycoprotein I upon the content of cAMP and GMP in human blood platelets. Thromb Haemost 1985; 54: 824-827.
18. Nimf J, Wurm H, Kostner J. β2-Glycoprotein I inhibits the release reaction of human platelets during ADP induced aggregation. Atherosclerosis 1987; 63: 109-114.
19. Nimpf J, Bevers E, Bomans P, et al. Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochim Biophys Acta 1986; 884: 142-149.
20. Arcieaux J, Roussel B, Jacob M, et al. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Method 1991; 143: 223-229.
21. Viard J, Amoura Z, Bach J. Association of anti-β2-glycoprotem I antibodies with lupus-type circulating anticoagulant and thrombosis in SLE. Am J Med 1992; 93: 181-186.
22. Cabral A, Rodriguez M, Cabiedes J, et al. Antibodies to β2-glycoprotein I associate with antiphospholipid syndrome whether primary or secondary to SLE. Arthritis Rheum 1993; 6(Suppl.): S242.
23. Balestrieri G, Tincani A, Spatula L, et al. Anti-β2-glycoprotein I antibodies: a marker of antiphospholipid syndrome Lupus 1995; 4: 122-130.
24. Del Papa N, Guildali L, Spatula L, et al. Relationship between antiphospholipid and antiendothelial cell antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheum 1995; 13: 179-185.
25. Brown H. Antiphospholipid antibodies and recurrent pregnancy loss. Clin Obstet Gynecol 1991; 34: 17-26.
26. Rustin N, Machin H, Isenberg S, et al. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol 1988; 90: 744-751.
27. Cariou R, Tobelem G, Bellucci C, et al. Effects of lupus anticoagulant on antithrombogenic properties on endothelial cells - inhibition of thrombomodulin activation. Thromb Haemost 1988; 60: 54-59.
28. Harris E, Gharavi A, Hughes G. Antiphospholipid antibodies. Clin Rheum Dis 1985; 11: 591-600.
29. Kornberg A, Blank M, Kaufman S, et al. Tissue procoagulant induction by antiphospholipid antibodies. J Immunol 1994; 153: 1328-1332.
30. Vianna J, Khamashta M, Ordi-Ross J, et al. Comparison of the primary and the secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 3-9.
31. Lockshin M. Lupus and antiphospholipid antibody syndrome: either, neither or both. Am J Med 1994; 96: 1-2.
32. Asherson R. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.
33. Alerge V, Gastineau D, Winkelman R. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989; 120: 419-429.
34. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
35. Coperman P. Livedo reticularis: signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol 1975; 93: 519-529.
36. Champion R, Rook A. Livedo reticularis. Proc R Soc Med 1960; 53: 961-962.
37. Sneddon J. Cardiovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180-185.
38. Hughes G. Connective tissue disease and the skin. Prosser White Oration 1983. Clin Exp Dermatol 1984; 9: 535-544.
39. Weinstein C, Miler M, Axtens R, et al. Livedo reticularis associated with increased titres of anticardiolipin antibodies in SLE. Arch Dermatol 1987; 113: 596-600.
40. McHugh M, Maymo J, Skinner R, et al. Anticardiolipin antibodies, livedo reticularis and major cerebrovascular and renal disease in SLE. Ann Rheum Dis 1988; 47: 110-115.
41. Asherson R, Mayou S, Merry P, et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989; 120: 215-221.
42. Bowie E, Thompson J, Pascuzzi C, et al. Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
43. Alarcon-Segovia D, Deluxe M, Oria C, et al. Antiphospholipid antibodies and antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
44. Alarcon-Segovia D, Perez-Varquez M, Villa A, et al. Preliminary classification criteria for the antiphospholipid syndrome with lupus systemic erythematosus. Semin Arthritis Rheum 1992; 21: 275-286.
45. Stephansson E, Niemi K, Jouhikainen T, et al. Lupus anticoagulant and the skin. Acta Derm Venereol 1991; 71: 416-422.
46. Johanson E, Niemi K, Mustalillio KK. A peripheral vascular syndrome overlapping with SLE. Dcrmatologica 1977; 155: 257-267.
47. Cuny J, Schmutz J, Jeandel C, et al. Ulcere de jambe et anticoagulants circulants. Ann Dermatol Venereol 1986; 113: 825-826.
48. Englert H, Hawkes C, Boey M, et al. Degos' disease: association with anticardiolipin antibodies and lupus anticoagulant. Br Med J 1984; 289: 576.
49. Assier H, Chosidow O, Piette J, et al. Absence of antiphospholipid and antiendothelial cell antibodies in malignant atrophic papulosis: a study of 15 cases. J Am Acad Dermatol 1995; 33: 831-833.
50. Grob J, Bonerandi J. Thrombotic skin disease as a marker of anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol 1989; 20: 1063-1069.
51. Naldi L, Marchesi L, Finazzi G, et al. Antiphospholipid antibodies and necrotizing purpura. Dermatologica 1990; 180: 272-275.
52. Lalova A, Gantcheva M. Intralesional steroids as a treatment of leg ulcers caused by antiphospholipid syndrome, 5th Annual Meeting of the European Tissue Repair Society, Padova, Italy, 1995, p. 86.
53. Tishler M, Papo J, Yaron M. Skin ulcer as the presenting symptom of primary antiphospholipid syndrome -resolution with anticoagulant therapy. Clin Rheumatol 1995; 14: 112-114.
54. Barbaud A, Gobert B, Reichert S, et al. Anticardiolipin antibodies and ulcerations of the leg. J Am Acad Dermatol 1994; 31: 670-671.
55. Asherson R, Khamastra M, Ordi-Ros J, et al. The primary antiphospholipid syndrome: major clinical and pathological features. Medicine 1989; 68: 366-374.
56. Grob J, Bonerandi J. Cutaneous manifestations associated with the presence of the lupus anticoagulant: a report of two cases and review of the literature. J Am Acad Dermatol 1986; 15: 211-219.
57. Farant J, Judge M, Thompson R. Thrombotic cutaneous nodules and hepatic vein thrombosis in the antiphospholipid syndrome. Clin Exp Dermatol 1989; 14: 306-310.
58. Asherson R, Jacobelli S, Rosenberg H, et al. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome. Clin Exp Dermatol 1991; 17: 166-269.
59. Grob J, San Marco M, Ailland M, et al. Unfading acral microlivedo. J Am Acad Dermatol 1991; 24: 53-58.
60. Asherson R. Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy? Ann Rheum Dis 1990; 49: 268.
61. Ames D, Asherson R, Ayres B, et al. Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the primary antiphospholipid syndrome. Br J Rheumatol 1992; 31: 117-120.
62. Frances C, Piette J, Saada V, et al. Multiple subungual splinter haemorrhages in the antiphospholipid syndrome. A report of 5 cases and review of the literature. Lupus 1994; 3: 123-128.
63. Disdier P, Harle J, Andrac L, et al. Primary anetoderma with the antiphospholipid syndrome. J Am Acad Dermatol 1994; 30: 133-134.
64. Davies G, Triplett D. Corticosteroid associated blue toe syndrome: role of antiphospholipid antibodies. Ann Int Med 1990; 113: 893-895.
65. Hill V, Wittaker S, Hunt B, et al. Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides. Br J Dermatol 1994; 130: 92-96.
66. Castanet J, Lacour J, Perrin C, et al. Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody. Dermatology 1994; 189: 304-307.
67. Asherson R, Hughes G. Recurrent deep vein thrombosis and Addison's disease in primary antiphospholipid syndrome. J Rheumatol 1989; 16: 378-380.
68. Tsankov N, Krasteva M, Nikolov K, Gantcheva M. Antiphospholipid syndrome. Presented at the Annual Sofia Days, November 1993.
69. Mayou S, Wojnovowstrae E, Lovell C, et al. Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus: their clinical significance. Br J Dermatol 1987; 116: 445.
70. Dodd H, Sarkany I, O'Shangnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985; 10: 581-588.
71. O'Neill A, Gatenby P, McGaw P, et al. Widespread cutaneous necrosis associated with anticardiolipin antibodies. J Am Acad Dermatol 1990; 22: 356-359.
72. Berth-Jones J, Hutchinson P, Wicks A, et al. Discoid lupus erythematosus associated with the anticardiolipin syndrome. Br J Dermatol 1989; 120: 469-474.
73. Frances C, Tribout B, Boisnic S, et al. Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 1989; 178: 194-201.
74. Lie J. Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis or both? J Rheumatol 1989; 16: 713-715.
75. Lie J. The distinction between vasculitis coincidental with one that is causally related to the antiphospholipid syndrome. Arthritis Rheum 1992; 35: 15-40.
76. Lie J. Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 1994; 21: 397-399.
77. Praderio L, D'Angelo A, Taccagni G, et al. Association of lupus anticoagulant with polyarteritis nodosa: report of a case. Haematologica 1990; 75: 387-390.
78. Norden D, Ostrov B, Shafritz A, et al. Vasculitis associated with antiphospholipid syndrome. Sem Arthr Rheum 1995; 24: 273-281.
79. Cid M, Cervera R, Font J, et al. Recurrent arterial thrombosis in a patient with giant cell arteritis and raised anticardiolipin antibody levels. Br J Rheumatol 1988; 27: 164-166.
80. McHugh N, James I, Plant J. Anticardiolipin and antineutrophil antibodies in giant cell arteritis. J Rheumatol 1990; 17: 916-922.
81. Watts M, Greaves M, Clearkin L, et al. Antiphospholipid antibodies and ischaemic optic neuropathy. Lancet 1990; 335: 613-614.
82. Hull R, Harris E, Gharavi A, et al. Anticardiolipin antibodies: occurrence in Behcet's syndrome. Ann Rheum Dis 1984; 43: 746-748.
83. Gantcheva M, Lalova A, Kamarashev J. Antiphospholipid syndrome associated with vasculitis. Curr Intern 1996; 2/3: 22-23.
84. Alarcon-Segovia D, Cardiel M, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol 1989; 16: 762-767.
85. Goldberg E, Elder R, Schwartz R, et al. Vasculitis in the antiphospholipid syndrome. A case of ischemia responding to corticosteroids. Arthritis Rheum 1992; 35: 569-572.
86. Lalova A, Popov J, Dourmishev A, et al. Dramatic vasculopathy in a patient with antiphospholipid syndrome. Acta Dermatol Venereol 1996; 76: 406.
87. Greisman S, Thayaparan R, Godwin T, et al. Occlusive vasculopathy in SLE: association with anticardiolipin antibody. Arch Int Med 1991; 151: 389-392.
88. Gertner E, Lie J. Pulmonary capillaritis, alveolar haemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993; 10: 1224-1228.